Albanese, Gaetana

The Diabetic Cardiomyopathy: The Contributing Pathophysiological Mechanisms

Salvatore, T., Pafundi, P. C., Galiero, R., Albanese, G., Di Martino, A., Caturano, A., Vetrano, E., Rinaldi, L., & Sasso, F. C. (2021) · Frontiers in Medicine

Cardiovascular Function and Risk FactorsCardiac Fibrosis and Remodeling

Cited by 165

Coronary Microvascular Dysfunction in Diabetes Mellitus: Pathogenetic Mechanisms and Potential Therapeutic Options

Salvatore, T., Galiero, R., Caturano, A., Vetrano, E., Loffredo, G., Rinaldi, L., Catalini, C., Gjeloshi, K., Albanese, G., Di Martino, A., et al. (2022) · Biomedicines

Cardiovascular Function and Risk FactorsCardiac Imaging and Diagnostics

Cited by 98

Can Metformin Exert as an Active Drug on Endothelial Dysfunction in Diabetic Subjects

Salvatore, T., Pafundi, P. C., Galiero, R., Rinaldi, L., Caturano, A., Vetrano, E., Aprea, C., Albanese, G., Di Martino, A., Ricozzi, C., et al. (2020) · Biomedicines

Nitric Oxide and Endothelin EffectsDiabetes Treatment and Management

Cited by 97

Dysregulated epicardial adipose tissue as a risk factor and potential therapeutic target of heart failure with preserved ejection fraction in diabetes

Salvatore, T., Galiero, R., Caturano, A., Vetrano, E., Rinaldi, L., Coviello, F., Di Martino, A., Albanese, G., Colantuoni, S., Medicamento, G., et al. (2022) · Biomolecules

Cardiovascular Disease and AdiposityCardiovascular Function and Risk Factors

Cited by 62